Literature DB >> 28835392

Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease.

Qi Xu1,2, Monica Langley3, Anumantha G Kanthasamy3, Manju B Reddy4.   

Abstract

Background: Parkinson disease (PD) is a neurodegenerative disorder that has been associated with many factors, including oxidative stress, inflammation, and iron accumulation. The antioxidant, anti-inflammatory, and iron-chelating properties of epigallocatechin gallate (EGCG), a major polyphenol in green tea, may offer protection against PD.Objective: We sought to determine the neurorescue effects of EGCG and the role of iron in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD.
Methods: We evaluated the neurorescue effect of EGCG (25 mg/kg, 7 d, oral administration) against MPTP-induced (20 mg/kg, 3 d, intraperitoneal injection) neurodegeneration in C57 male black mice. Thirty mice weighing ∼25 g were divided into 3 groups: control, MPTP, and MPTP + EGCG. The neurorescue effect of EGCG was assessed with the use of motor behavior tests, neurotransmitter analysis, oxidative stress indicators, and iron-related protein expression.
Results: Compared with the control group, MPTP treatment shortened the mice's latency to fall from the rotarod by 16% (P < 0.05), decreased the striatal dopamine concentration by 58% (P < 0.001) and dihydroxyphenylacetic acid by 35% (P < 0.05), and increased serum protein carbonyls by 71% (P = 0.07). However, EGCG rescued MPTP-induced neurotoxicity by increasing the rotational latency by 17% (P < 0.05) to a value similar to the control group. Striatal dopamine concentrations were 40% higher in the MPTP + EGCG group than in the MPTP group (P < 0.05), but the values were significantly lower than in the control group. Compared with the MPTP and control groups, mice in the MPTP + EGCG group had higher substantia nigra ferroportin expression (44% and 35%, respectively) (P < 0.05) but not hepcidin and divalent metal transporter 1 expression.
Conclusion: Overall, our study demonstrated that EGCG regulated the iron-export protein ferroportin in substantia nigra, reduced oxidative stress, and exerted a neurorescue effect against MPTP-induced functional and neurochemical deficits in mice.
© 2017 American Society for Nutrition.

Entities:  

Keywords:  EGCG; MPTP; Parkinson disease; ferroportin; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28835392      PMCID: PMC5610551          DOI: 10.3945/jn.117.255034

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  52 in total

1.  Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages.

Authors:  M Lin; R A Rippe; O Niemelä; G Brittenham; H Tsukamoto
Journal:  Am J Physiol       Date:  1997-06

2.  Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.

Authors:  Zhanyun Lv; Hong Jiang; Huamin Xu; Ning Song; Junxia Xie
Journal:  J Neural Transm (Vienna)       Date:  2010-06-17       Impact factor: 3.575

3.  Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity.

Authors:  Hilary Afeseh Ngwa; Arthi Kanthasamy; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2013-12-18       Impact factor: 4.294

4.  Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action.

Authors:  Yona Levites; Tamar Amit; Moussa B H Youdim; Silvia Mandel
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

5.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

6.  Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys.

Authors:  Yi He; Patricia S Thong; Timothy Lee; S K Leong; Bo Y Mao; Fang Dong; Frank Watt
Journal:  Free Radic Biol Med       Date:  2003-09-01       Impact factor: 7.376

7.  Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson's disease.

Authors:  L-H You; F Li; L Wang; S-E Zhao; S-M Wang; L-L Zhang; L-H Zhang; X-L Duan; P Yu; Y-Z Chang
Journal:  Neuroscience       Date:  2014-10-06       Impact factor: 3.590

8.  Expression and cellular localization of hepcidin mRNA and protein in normal rat brain.

Authors:  Ruma Raha-Chowdhury; Animesh Alexander Raha; Serhiy Forostyak; Jing-Wei Zhao; Simon Russell William Stott; Adrian Bomford
Journal:  BMC Neurosci       Date:  2015-04-21       Impact factor: 3.288

9.  Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.

Authors:  Anamitra Ghosh; Arthi Kanthasamy; Joy Joseph; Vellareddy Anantharam; Pallavi Srivastava; Brian P Dranka; Balaraman Kalyanaraman; Anumantha G Kanthasamy
Journal:  J Neuroinflammation       Date:  2012-10-23       Impact factor: 8.322

10.  Rapid responses to oxidative stress mediated by iron regulatory protein.

Authors:  K Pantopoulos; M W Hentze
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  31 in total

Review 1.  Impact of dietary polyphenols on neuroinflammation-associated disorders.

Authors:  Neeraja Revi; Aravind Kumar Rengan
Journal:  Neurol Sci       Date:  2021-05-14       Impact factor: 3.307

2.  Epigallocatechin gallate in multiple system atrophy (PROMESA).

Authors:  Kurt A Jellinger
Journal:  Ann Transl Med       Date:  2019-12

Review 3.  Perspectives on the recent developments with green tea polyphenols in drug discovery.

Authors:  Feng Li; Yongli Wang; Dapeng Li; Yilun Chen; Xuguang Qiao; Rania Fardous; Ashton Lewandowski; Jinbao Liu; Tak-Hang Chan; Q Ping Dou
Journal:  Expert Opin Drug Discov       Date:  2018-04-24       Impact factor: 6.098

4.  Epigallocatechin-3-gallate improves chronic alcohol-induced cognitive dysfunction in rats by interfering with neuro-inflammatory, cell death and oxido-nitrosative cascade.

Authors:  Ankit Uniyal; Vineeta Tiwari; Anagha Gadepalli; Obulapathi Ummadisetty; Vinod Tiwari
Journal:  Metab Brain Dis       Date:  2021-08-12       Impact factor: 3.584

Review 5.  Polyphenols in Parkinson's Disease: A Systematic Review of In Vivo Studies.

Authors:  Małgorzata Kujawska; Jadwiga Jodynis-Liebert
Journal:  Nutrients       Date:  2018-05-19       Impact factor: 5.717

6.  Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment.

Authors:  Xian-Si Zeng; Wen-Shuo Geng; Jin-Jing Jia
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

7.  Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism.

Authors:  Tuo Liang; Zhong-Ming Qian; Ming-Dao Mu; Wing-Ho Yung; Ya Ke
Journal:  iScience       Date:  2020-06-19

Review 8.  Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.

Authors:  Priscila Baltazar Gonçalves; Ana Carolina Rennó Sodero; Yraima Cordeiro
Journal:  Biomolecules       Date:  2021-05-20

9.  The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question-are polyphenols a viable therapeutic option against proteinopathies?

Authors:  Gal Bitan
Journal:  Ann Transl Med       Date:  2020-06

Review 10.  Catechins as Tools to Understand the Molecular Basis of Neurodegeneration.

Authors:  Karla Martinez Pomier; Rashik Ahmed; Giuseppe Melacini
Journal:  Molecules       Date:  2020-08-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.